Oct 24, · Bitcoin is now caught within an intense uptrend that has sent its price rocketing up to fresh yearly highs, with bulls currently testing these highs as they target further upside This strength has come about due to the confluence of multiple positive news developments and has allowed BTC to far outperform the stock market. Bitcoin spent almost its entire lifecycle having next to no correlation between its price action and the stock market. Big-name investors claimed its uncorrelated price action made it a great addition to any investment portfolio. Oct 16, · Market analysts have repeatedly asked whether stocks and bitcoin are correlated. Long story short, it depends on one's time frame. In the short Author: Charles Bovaird.
Is bitcoin tied to stock marketBest Cryptocurrency Stocks for | The Motley Fool
Penny stocks are well-known for their volatility aside from just their cheap price. First, understand what you're buying and why you're buying it. Just saying you trade penny stocks isn't the goal. You're in the market to make money. So, identifying entry and exit targets are obviously important. What's more, is you should have a basic strategy in mind.
Are you looking at day trading penny stocks or do you have a longer-term idea in mind? Also, it's important to account for the swings in price and how fast they're happening. Case in point, small-cap stocks are red hot right now. When finding penny stocks to buy, make sure you assess each trade independently and plan accordingly. Furthermore, day traders wouldn't normally jump into a stock that is barely fluctuating in price. As a rule of thumb, the lower the price, the higher the volatility.
That's simply for the fact that a small move in price equates to a larger percentage change. This week the company came out with news that it finished the purchase of roughly 44 acres in Montana.
This will be the site for its vaccine development and manufacturing facility. This adds to the growing footprint of the company as well. These two facilities will support the development and production of the company's vaccine candidates. Specifically, the TNX has been a center of attention as you could imagine. Many coronavirus vaccine stocks have garnered interest over the last few months.
In this case, Tonix is aiming to report efficacy data from animal challenge studies of the vaccine candidate next quarter. Unlike other biotech's Biolase is mainly focused on products used in oral health.
The company's main products are dental laser systems that perform a wide range of procedures, including cosmetic and complex surgical applications. Last month the company launched Waterlase Endo Academy to foster education and best practices for integrating Waterlase technology in clinical settings. Jaguar Health Inc. While we've reported on the company for weeks, the bigger move this week comes after Jaguar's latest update.
The company signed an agreement for a non-dilutive royalty financing transaction. Lisa Conte, Jaguar's president and CEO, explained that, "The timing of this transaction aligns well with the progress of the recently initiated pivotal Phase 3 trial for CTD, for which patient enrollment is progressing.
There's a potential deal with the SPAC and an operational subsidiary of Jaguar to be established in Europe with an exclusive license to crofelemer and Mytesi for the indications of inflammatory diarrhea and HIV-related diarrhea.
Senseonics Holdings Inc. Senseonics was granted a patent titled, "Remotely-powered sensing system with multiple sensing devices. Senseonics' implantable glucose monitoring systems are used by diabetes patients.
This communicates with a smart transmitter worn over the sensor. Data are then sent every five minutes to a mobile app on the user's smartphone. Adding to the reasons to watch Senseonics, earlier this year the company entered a collaboration with Ascensia Diabetes Care, a global diabetes care company.
Heading into the beginning of , there are a few things traders are following. One of these things is the initiation of commercial activities outside of the US with the help of Ascensia. The company also expects a decision on approval of its Eversense product by the FDA in the first half of the year. Neither the author of this post nor Pennystocks.
Ah, "Carnival. And some cruise lines are about to resume trips. So is this a good time or bad time to invest in Carnival?
Finally, a chance that the lockdown and social distancing regimes truly are going to end, and in the near-term. There is a real chance that, by the end of a , John Q. Public may be getting back on his feet. A return to grass roots normalcy will be great — but we also have the prospect of an overall rising market. Risks relating to global trade tensions, political uncertainty, and the pandemic, will be going away. Sotera Health SHC Sotera Health occupies a unique niche in the healthcare industry, offering, through its subsidiaries, a range of safety-oriented support businesses for healthcare providers.
These services include sterilization procedures, lab testing, and advisory services — and their importance is immediately clear. Sotera boasts over 5, healthcare provider customers in more than 50 countries around the world. While not a new company — two of its branches have been in business since the s and 40s — Sotera is new to the stock markets, having held its IPO just this past November. That facility is currently undrawn.
This clinical research biopharma company focuses on major issues of reproductive system disease in both men and women. Specifically, Myovant is working to develop treatments for uterine fibroids, endometriosis, and prostate cancer. The drug is in Phase 3 trial for the latter, and has had its NDA submitted for the former.
Also in the pipeline, and related to reproductive health, is MVT, a new drug designed to enhance egg maturation and aid in vitro fertilization. In addition, Myovant has announced this month that Relugolix has been FDA approved — under the brand name Orgovyx — as a treatment for advanced prostate cancer. Orgovyx is expected to enter the market in January Further, we see an attractive commercial setup for relugolix in the treatment of advanced prostate cancer as an oral LHRH alternative with a differentiated CV risk profile.
In a year that has been difficult for most of us, MCB has managed to post steadily increasing revenues and solid earnings. In this environment, he sees Metropolitan Bank as the right choice. Having witnessed many cycles in NYC, the time to buy has been when the herd is running in the other direction. Alexopoulos' is the only recent analyst review of this company, and it is decidedly positive. Owning a home might be the epitome of the American dream, but it's not engraved in stone!
So, if you've been toying with the idea of giving up homeownership, then, by all means, go for it. However, given that homeownership is perceived as the hallmark of wealth, giving it up is set to bring you a lot of controversies.
Individuals in your circle might even criticize. But regardless of what the greater population thinks, here are good reasons never to buy a home. Homeownership Costs Are Lifelong Advocates for homeownership often argue that paying rent is costly, but homeownership is equally as expensive. Homeownership costs do not end with that initial payment. It comes with lifelong costs, which, compared to renting, will create a dent in your finances and take away your peace of mind.
For instance, utility bills like electricity and water are unavoidable and must be paid every month. Add in recurring costs like insulation, heating and cooling maintenance costs, homeowners insurance, property taxes, HOA fees, mortgage payments, and yard maintenance, and chances are you end up spending more annually than a renter residing in a house similar to yours.
What's more, there's no opting out. Once you purchase a home, you commit to these costs unless you decide to sell it. On the other hand, when you lease or rent a home, you can always opt-out. For example, when times become hard, you can always shift to income based apartments until you're back on your feet again. Although there's some truth in this, buying a house as your primary residence is not the same as buying one to rent out or resale.
Well, when you purchase a home for real estate, it brings you a return on investment. For instance, when you purchase a condo and rent or lease it out, it offers you returns on investment at least every month or every six months based on the terms of your agreement with your tenant. But when you purchase a home to live in, you will have invested, but you will not get any returns.
If anything, you will be the one putting money into it through maintenance, mortgage payments, and all other costs mentioned earlier. Plus, a house can never be an investment if you don't plan on selling it at any point. What makes an investment an investment is your control over its ownership.
In other words, a real estate investment is referred to as such because you can buy it when its value is low and sell it when the value is high, making profits. But your primary residence is different because you cannot just wake up one morning and decide to sell it unless you are hard-pressed for cash, which in most cases means you will take any offer leading to losses.
Also, when you sign that home-buying agreement, your money is automatically locked down, and the only way you can get it back is by selling it or taking a home equity loan. When you rent or lease, you free up your cash, and you can use it to invest in opportunities that grow your wealth. Sure, you could argue that rent is expensive, but this is not a good enough reason to buy a home since there are plenty of modern, well-equipped, low-income apartments that'll help you keep costs low.
That means selling it will bring you good profits. However, keep in mind that the real estate market is incredibly volatile. For instance, during the great financial recession of , real estate market values experienced a sharp decline, which saw sellers incur massive losses.
What does this have to do with buying a home? Well, you may buy a home expecting it to increase in value, but instead, find that its value is incredibly low when you badly need to sell it off. The result? Share Tweet Send Share. Prev Next. For updates and exclusive offers enter your email below.
Investing Best Accounts. Stock Market Basics. Stock Market. Industries to Invest In. Getting Started. Planning for Retirement. Retired: What Now? Personal Finance. Credit Cards. About Us. Who Is the Motley Fool? Fool Podcasts. New Ventures.
Search Search:. Oct 14, at AM. You'll often find him writing about Obamacare, marijuana, drug and device development, Social Security, taxes, retirement issues and general macroeconomic topics of interest.